Case Study: Orion Pharma improves clinical trial predictability with Qentinel Value Creation Model

Value Creation Model™ Helped Orion Pharma to Identify Improvement Points in the Partner Ecosystem

Orion R&D, represented in this case study by Orion Pharma R&D, needed a better way to improve the predictability of its clinical trials. Like much of the pharma industry, Orion faced delays driven by patient recruitment and wanted to move from reactive ecosystem management to earlier identification of risks across its network of vendors and collaborators. Qentinel’s Quality Intelligence with Value Creation Model™ was used to help visualize the clinical trial ecosystem and its interdependencies.

With Qentinel’s Value Creation Model™, Orion Pharma was able to identify intervention points, see the big picture of partner connections, and support more proactive decision-making in its Lean initiative. The solution helped shift collaborator management and communication from reactive to proactive, opened up mutually beneficial discussions across the ecosystem, and laid the groundwork for real-time measurement to help prevent program delays.

Orion R&D

Taru Blom

Vice President, Development